Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents

Lismidiati, Wiwin; Emilia, Ova; Widyawati, Widyawati

doi:10.31557/APJCP.2019.20.10.2959

Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents

Document Type : Research Articles

Authors

¹ Department of Pediatric and Maternity Nursing, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia.

² Department of Medical Education, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia.

10.31557/APJCP.2019.20.10.2959

Abstract

Background:The incidence of Human Papillomavirus (HPV) infection and cervical cancer in adulthood may be
prevented by HPV vaccination in adolescence. Currently, the HPV vaccination coverage rate in developing countries is
about 15%. The reason for this low vaccination coverage is most likely due to a lack of information among adolescents
and adults. Purpose: To explore adolescents, parents and teachers’ needs, obstacles, and expectations around the HPV
vaccination. Methods: This research used a qualitative method with a focus group discussion. The research participants
were divided into three groups: 21 female students, 17 parents, and 20 teachers. This research was conducted in junior
high schools that have programs run by their adolescent reproductive health counseling information centers. The data
were analyzed by employing content analysis. Results: HPV vaccination has not been made a priority for adolescents
because: 1) There is a lack of available education about HPV and HPV vaccinations for adolescents, parents, and
teachers. 2) The high cost for parents to vaccinate their children. 3) Adolescents, parents and teachers believe that the
HPV vaccine needs to be administered to adolescents, but they feel that the vaccine is not affordable. Conclusion: It is
important to consider a program which will provide accurate information about the HPV vaccination to the community,
especially adolescents. Financial management, such as insurance or vaccination savings schemes, may be one way to
overcome the problem of the HPV vaccination’s cost.

Keywords

Main Subjects